-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Vaxcyte (PCVX)
-
-
-
-
-
-
-
Vaxcyte (PCVX) PT Lowered to $116 at Guggenheim
-
-
-
-
-
-
-
Jefferies on Vaxcyte (PCVX): 'this data increasing PCVX's fundamental value'
-
-
-
-
-
-
-
Goldman Sachs Starts Vaxcyte (PCVX) at Buy
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Vaxcyte (PCVX)
-
-
-
-
-
-
-
Vaxcyte, Inc (PCVX) September 105 puts active as share price up 37%
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Vaxcyte (PCVX)
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

